ReviewBiomedicines2021

Targeting Inflammasome Activation in COVID-19: Delivery of RNA Interference-Based Therapeutic Molecules.

Lealem Gedefaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.